Dr Jessica Barreto in Holualoa, HI - Chiropractor

Dr Jessica Barreto is a Chiropractor based in Holualoa, Hawaii. Dr Jessica Barreto is licensed to practice in Hawaii (license number DC1336) and their current practice location is 75-5526 Kealia St, Holualoa, Hawaii. It can be reached at their office (for appointments etc.) via phone at (808) 329-6997.

NPI number for Dr Jessica Barreto is 1811343510 and their current mailing address is 75-5526 Kealia St, Holualoa, Hawaii. Dr Jessica Barreto does not participate in medicare program and thus does not accept medicare assignments. The facility's NPI Number is 1811343510.

Contact Information

	Dr Jessica Barreto
	75-5526 Kealia St, Holualoa, HI 96725-9613
	(808) 329-6997
	(808) 329-6987

Healthcare Provider's Profile

Full Name	Dr Jessica Barreto
Type	Facility
Speciality	Chiropractor
Location	75-5526 Kealia St, Holualoa, Hawaii
Accepts Medicare Assignments	Does not participate in Medicare Program. The facility may not accept medicare assignment.

NPI Data:

NPI Number: 1811343510
Provider Enumeration Date: 05/11/2016
Last Update Date: 05/11/2016

Medical Identifiers

Medical identifiers for Dr Jessica Barreto such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1811343510	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
111N00000X	Chiropractor	DC1336 (Hawaii)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Jessica Barreto is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Jessica Barreto 75-5526 Kealia St, Holualoa, HI 96725-9613 Ph: (808) 329-6997	Dr Jessica Barreto 75-5526 Kealia St, Holualoa, HI 96725-9613 Ph: (808) 329-6997

News Archive

Tacere announces reacquisition of HCV compound development, commercialization rights in Asia

Tacere Therapeutics, an RNA interference (RNAi)-based therapeutics company, announced today that it has reacquired the development and commercialization rights to its Hepatitis C Virus compounds throughout Asia from its strategic partner, Tokyo-based Oncolys BioPharma Inc.

Intuitive mind-reading in infants

One of the unique characteristics of humans that distinguish us from the animal kingdom is the ability to represent others, beliefs in our own minds.

Surgeons remove 11-pound desmoid tumor, transplant bowel back into patient

Surgeons at the University of Illinois Medical Center at Chicago removed an 11-pound desmoid tumor from the abdominal cavity of an Arkansas man and performed a transplant using a segment of his own small intestine rescued during surgery, preserving his ability to eat and digest food.

Reviewing applications of advanced materials in drug delivery and biomedicine

The Graphene family of materials has emerged as one of the most useful new age nano-biomaterials. Graphene-based materials exhibit excellent physicochemical properties, such as high electrical conductivity, mechanical strength, and high surface area with π-conjugated carbon atoms stacked to form honeycomb structure, suitable for binding other molecules.

Amsterdam Molecular Therapeutics commences preregistration trial for Glybera

Amsterdam Molecular Therapeutics announced today the treatment of the first patient in a preregistration clinical trial with Glybera. This gene therapy product targets lipoprotein lipase deficiency (LPLD), a seriously debilitating and potentially lethal disease.

Dr Jessica Barreto - Chiropractor in Holualoa, HI